Search
Bayer HealthCare Links
Bayer Dermatology
Company Brochure
Annual Report
Press portal
Clinical trials
Information about clinical studies is available at database of
News
-
2012-02-20 | Worldnews
Positive One Year results From Phase 3 Study in Central Retinal Vein Occlusion of VEGF Trap-Eye
2012-02-20 | Worldnews
Positive One Year results From Phase 3 Study in Central Retinal Vein Occlusion of VEGF Trap-Eye
-
2012-02-16 | Worldnews
Bayer Acquires Animal Health Business from KMG Chemicals
2012-02-16 | Worldnews
Bayer Acquires Animal Health Business from KMG Chemicals
Acquisition will strengthen Bayer HealthCare’s Animal Health insecticides business more
-
2012-01-18 | Worldnews
Bayer’s Xarelto® Approved in Japan for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
2012-01-18 | Worldnews
Bayer’s Xarelto® Approved in Japan for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
-
2012-01-18 | Cancer
Positive Phase III Data on Bayer’s Investigational Drug Regorafenib Show Significant Increase in Overall Survival
2012-01-18 | Cancer
Positive Phase III Data on Bayer’s Investigational Drug Regorafenib Show Significant Increase in Overall Survival
First presentation of data from CORRECT trial as “Late Breaking Abstract” at the 2012 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI) more
-
2012-01-10 | Cancer
Phase III Data of Bayer’s Regorafenib in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Oral Presentation at 2012 ASCO-GI Congress
2012-01-10 | Cancer
Phase III Data of Bayer’s Regorafenib in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Oral Presentation at 2012 ASCO-GI Congress
Late breaking abstract (LBA #385) of Phase III CORRECT study results to be presented on January 21, 2012 more
